Ornskov Eivor, Linusson Anna, Folestad Staffan
Pharmaceutical and Analytical R&D, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden.
J Pharm Biomed Anal. 2003 Oct 15;33(3):379-91. doi: 10.1016/s0731-7085(03)00238-3.
The utility of capillary electrophoresis (CE) for determination of the negative logarithm of dissociation constants (pK(a)) of labile compounds was investigated. In this study pyridinyl-methyl-sulfinyl-benzimidazoles (PMSB's), which have both an acidic and a basic pK(a), were selected as a first set of model drug compounds. This is a group of compounds that are known to degrade in aqueous solutions under neutral and acidic conditions which thus may impair their pK(a) determination when using common batch techniques based on spectrophotometry or potentiometry. An additional set of model drug compounds, benzenesulfonic acid phenethyloxy-phenyl esters (BSAP's), which are labile at high pH, were also studied. It is demonstrated that pK(a) values can be determined with high precision and accuracy by CE for both these sets of model compounds because decomposition products and impurities can be sufficiently separated from the main component. Based on the results in this study, a general strategy is proposed and discussed for determination of pK(a) for labile compounds. Key steps comprise use of a stabilizing sample diluent, injection by electromigration, short analysis time, and characterization of the main component by UV-Vis spectra.
研究了毛细管电泳(CE)用于测定不稳定化合物解离常数的负对数(pK(a))的实用性。在本研究中,选择了具有酸性和碱性pK(a)的吡啶基-甲基-亚磺酰基-苯并咪唑(PMSB)作为第一组模型药物化合物。这是一类已知在中性和酸性条件下于水溶液中降解的化合物,因此在使用基于分光光度法或电位法的常规批量技术时,可能会影响其pK(a)的测定。还研究了另一组模型药物化合物,即苯磺酸苯乙氧基苯酯(BSAP),它们在高pH值下不稳定。结果表明,对于这两组模型化合物,CE均可高精度和准确地测定pK(a)值,因为分解产物和杂质能够与主要成分充分分离。基于本研究的结果,提出并讨论了一种用于测定不稳定化合物pK(a)的通用策略。关键步骤包括使用稳定的样品稀释剂、通过电迁移进样、缩短分析时间以及通过紫外-可见光谱对主要成分进行表征。